Herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (GCV) viral-directed enzyme prodrug gene therapy causes potent, tumor-selective cytotoxicity in animal models in which HSV-tk gene transduction is limited to a minority of tumor cells. The passage of toxic molecules from HSV-tk+ cells to neighboring HSV-tk-cells during GCV therapy is one mechanism that may account for this "bystander" cytotoxicity. To investigate whether gap junction-mediated intercellular coupling could mediate this bystander effect, we used a flow cytometry assay to quantitate the extent of heterocellular coupling between HSV-tk+ murine fibroblasts and both rodent and human tumor cell lines. Bystander tumor cytotoxicity during GCV treatment in a coculture assay was highly correlated (P < 0.001) with the extent of gap junctionmediated coupling. These (HSV-tk) to tumor cells (3-7). Transduced cells become sensitive to ganciclovir (GCV), a guanine analog that causes premature chain termination when incorporated into replicating DNA, thereby disrupting cellular proliferation (8, 9). The death of tumor cells not transduced with the HSV-tk transgene is called the "bystander effect" (3).
Current techniques for selective introduction of transgenes into brain tumors are capable of transducing only a minority of neoplastic cells. Although inoculation of C6 or 9L glioma tumors with fibroblasts producing retroviral vectors results in transduction of no more than 10% of tumor cells (1, 2) , curative gene therapy has been demonstrated in some animal models after retroviral transfer of the herpes simplex virus thymidine kinase gene (HSV-tk) to tumor cells (3) (4) (5) (6) (7) . Transduced cells become sensitive to ganciclovir (GCV), a guanine analog that causes premature chain termination when incorporated into replicating DNA, thereby disrupting cellular proliferation (8, 9) . The death of tumor cells not transduced with the HSV-tk transgene is called the "bystander effect" (3) .
Bystander cell killing occurs in cocultures of HSV-tk+ and unmodified HSV-tk-tumor cells when as few as 3% of cells express HSV-tk (10) . Bystander killing in the HSV-tk/GCV system requires direct contact between HSV-tk+ cells and bystander cells (11) and is not mediated by soluble factors (10, 12) . Toxic GCV metabolites transferred through gap junctions linking neighboring cells has been proposed as one possible mechanism of bystander killing (11, 13) . To investigate the basis of this effect, which appears critical to the efficacy of enzyme-prodrug cancer gene therapy strategies, we examined the relationship between gap junction-mediated intercellular communication and in vitro bystander cell killing. nexin43, as demonstrated by RNA blotting, immunoblotting, and immunofluorescence (data not shown).
MATERIALS AND METHODS
Formation of functional gap junctions between tumor cells was demonstrated by the intercellular transfer of Lucifer yellow. One minute after microinjection into a single tumor cell, Lucifer yellow was detected in 2 ± 5 (mean ± SD) C6 cells (n = 36), 1 ± 2 C6Cx43 cells (n = 63), 10 ± 4 9L19 cells (n = 40), and 32 ± 11 9L cells (n = 55). There were significant differences in coupling (ANOVA; P < 0.001) for comparisons between C6Cx43 and 9L19 cell lines and between 9L19 and 9L cell lines but not between C6 and C6Cx43 cell lines (P = 0.4). In cocultures of PKH26-labeled 9L cells with unlabeled PA317 fibroblasts, microinjection of Lucifer yellow into 9L cells resulted in Lucifer yellow transfer into neighboring fibroblasts (data not shown).
To measure differences in intercellular communication between cells with low connectivity, the microinjection technique would require a prohibitively large number of experiments. We used flow cytometry to allow rapid examination of large cell populations for quantitation of calcein dye transfer from calcein AM-labeled PA317 fibroblasts to PKH26-labeled tumor cells (17) . The staining patterns we observed are shown in a reconstruction experiment (Fig. 3) . Unstained C6 tumor cells evaluated by flow cytometry are shown in Fig. 3A . PKH26-labeled C6 cells and calcein AM-labeled C6 cells are shown in Fig. 3 B and C, respectively. C6 cells labeled with both dyes are shown in Fig. 3D . In these assays, PKH26-labeled tumor cells that also exhibited calcein fluorescence after 3.5 hr of coculture with calcein AM-labeled fibroblasts were scored as coupled cells.
Cell lines with various amounts of intercellular dye transfer are shown in Fig. 4 . We observed a sharp contrast in tumorto-fibroblast coupling between the C6 and 9L glioma cell lines. The C6 cell line coupled poorly with PA317 fibroblasts. Less than 10% of the PKH26-labeled C6 cells contained calcein dye after 3.5 hr of coculture with calcein AM-labeled PA317 cells (Fig. 4A) . When assayed under identical conditions, -95% of 9L cells were coupled (Fig. 4B ). There were significant differences in intercellular coupling between the C6, C6Cx43, 9L19, and 9L cell lines (in order of increasing coupling) and PA317 fibroblasts (Fig. 5) . Bystander killing efficiency in the coculture assay was highly correlated (P < 0.001) with the extent of coupling between tumor cells and fibroblasts for all nine tumor cell lines we have examined (Fig. 6) .
Effects of GCV on the Cell Cycle of Tumor Cells Cocultured with Fibroblasts. PA317 fibroblasts, both GCV treated and untreated, were analyzed daily by flow cytometry to determine the effect of GCV treatment on the cell cycle. Fig. 7 A and C shows DNA histograms demonstrating the cell cycle distribution of untreated PA317 cells and C6Cx43 tumor cells, respectively. Fig. 7B depicts the DNA histogram of PA317 cells exposed to 10 ,M GCV for 2 days. GCV-treated PA317 cells accumulate in late G1 and early S phases of the cell cycle. This effect was seen in viable cells after 1 and 2 days of GCV treatment, at which times most cells in the treated cultures were dead (data not shown). The S-phase arrest seen in the HSV-tk+ PA317 cells (Fig. 7B) was not present in HSV-tk-cell lines similarly treated (Fig. 7D) . after GCV treatment of cocultures when compared with C6Cx43 cells in untreated cocultures (Fig. 7E ). PA317 cells in these GCV-treated cocultures accumulated in the S phase, as did PA317 cells grown alone in the presence of GCV (data not shown). GCV had no effects on the cell cycle of either C6Cx43 tumor cells (Fig. 7 G and H While the bystander effect in vivo may be a complex phenomenon, possibly involving effects on tumor vasculature (25) or immune responses to tumor cells (4, 7), our coculture system allows examination of bystander killing in isolation from these effects. The strong correlation we observed between bystander killing and intercellular communication suggests that in vitro bystander killing is mediated by the transfer of toxic metabolites from HSV-tk+ PA317 fibroblasts to HSVtk-tumor cells through gap junctions.
Previous work on intercellular coupling provides precedents for this suggestion. The concept of metabolic coupling was proposed in 1969 (26) to describe intercellular transfer of molecules that alter the metabolism of recipient cells. Fujimoto et al. (27) used 6-thioguanine (6-TG) to select fibroblasts lacking hypoxanthine/guanine phosphoribosyltransferase (HGPT). These HGPT-cells, normally resistant to 6-TG, became sensitive to 6-TG when cocultured with HGPT+ fibroblasts. They suggested that metabolic coupling resulted in the transfer of toxic metabolites to the HGPT-cells, a process they termed "the kiss of death" (27) . Electron microscopy and microinjection experiments have shown that intercellular gap junctions are present in cells demonstrating metabolic coupling (28, 29 Previous studies have found no injury to normal cells surrounding tumors treated with GCV after HSV-tk gene transfer (31) . Because significant bystander killing is seen after GCV treatment of HSV-tk+ and HSV-tk-cell cocultures, the observed lack of damage to surrounding normal tissues may also indicate that bystander cytotoxicity is confined to or greatly enhanced in neoplastic tissue. Study of cell-to-cell interactions in tumors and normal tissues might help to explain the apparent resistance of normal cells to bystander killing.
Characterization of intercellular communication in different tumor types could serve several purposes. The identification of tumors that efficiently couple to delivery vehicle cells might determine optimal targets for therapies in which bystander cytotoxicity contributes to the therapeutic effect. Second, increased intercellular communication between tumor and delivery vehicle cells would be expected to increase bystander tumor cytotoxicity. Such approaches might include selecting cells that efficiently exchange molecules with specific tumor cell types, inserting genes important for formation of gap junctions into delivery cells, and the use of drugs to increase gap junction-mediated transfer. Further knowledge of the molecular mechanisms regulating intercellular communication may help to improve the therapeutic index of enzymeprodrug cancer treatment strategies.
